Merrimack Pharmaceuticals Cash from Financing (TTM) Insights

Merrimack Pharmaceuticals Inc (MACK)

14.71 +0.03 (+0.20%) USD | NASDAQ | Apr 19, 13:13

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2010. Upgrade now.

Date	Value
December 31, 2023	0.521M
September 30, 2023	6.921M
June 30, 2023	6.921M
March 31, 2023	6.712M
December 31, 2022	6.533M
September 30, 2022	0.00
June 30, 2022	0.00
March 31, 2022	0.00
December 31, 2021	0.239M
September 30, 2021	0.239M
June 30, 2021	0.183M
March 31, 2021	0.183M
December 31, 2020	-0.056M
September 30, 2020	-6.694M
June 30, 2020	-26.58M
March 31, 2020	-42.54M
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017	-379.16M

Date	Value
September 30, 2017	-320.37M
June 30, 2017	-320.65M
March 31, 2017	13.85M
December 31, 2016	9.416M
September 30, 2016	136.40M
June 30, 2016	176.01M
March 31, 2016	177.54M
December 31, 2015	180.16M
September 30, 2015	53.08M
June 30, 2015	13.96M
March 31, 2015	13.55M
December 31, 2014	11.42M
September 30, 2014	8.398M
June 30, 2014	154.24M
March 31, 2014	152.01M
December 31, 2013	150.29M
September 30, 2013	193.77M
June 30, 2013	46.73M
March 31, 2013	142.78M
December 31, 2012	142.30M
September 30, 2012	96.65M
June 30, 2012	96.05M
March 31, 2012	63.85M
December 31, 2011	76.30M
September 30, 2011	78.30M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-42.54M

Minimum

Mar 2020

6.921M

Maximum

Jun 2023

-2.964M

Average

0.183M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks